SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 66 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $135,000 | -26.6% | 30,162 | -10.4% | 0.01% | -31.2% |
| Q2 2021 | $184,000 | +44.9% | 33,676 | +97.8% | 0.02% | +33.3% |
| Q1 2021 | $127,000 | -40.4% | 17,026 | -13.2% | 0.01% | -47.8% |
| Q4 2020 | $213,000 | +131.5% | 19,606 | +46.9% | 0.02% | +360.0% |
| Q4 2019 | $92,000 | -60.3% | 13,351 | -67.9% | 0.01% | -66.7% |
| Q4 2018 | $232,000 | -17.7% | 41,587 | +117.3% | 0.02% | -78.9% |
| Q3 2017 | $282,000 | – | 19,139 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|